RxDoctor Payments Data

Diana Bratcher

Gerontology · Lexington, KYNPI 1326004946

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.3% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,078, 4.5 times the $242 reported in 2023.

$2,110in general payments, 2019–2025

Across 56 payments — averaging $37.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Idorsia Pharmaceuticals US Inc$315
  • Regeneron Healthcare Solutions, Inc.$209
  • Astellas Pharma US Inc$150
  • Sanofi$150
  • Scpharmaceuticals Inc.$143
  • Sumitomo Pharma America, Inc.$120
  • plus $1K from 20 others

What the payments were for

  • Speaking & faculty fees$1206%
  • Food & beverage$1,99094%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,110 in reported general payments places this provider in the 75th percentile of 84 gerontology providers in Kentucky.

See all gerontology providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
Teriflunomide11$84,349
EliquisApixaban29$15,828
JardianceEmpagliflozin15$8,847
XareltoRivaroxaban11$6,198
Atorvastatin Calcium61$4,235
Carvedilol ErCarvedilol Phosphate13$3,105
Mirabegron ErMirabegron12$3,060
Donepezil Hcl23$2,404
Ondansetron OdtOndansetron12$1,990
ClopidogrelClopidogrel Bisulfate19$1,600
Famotidine46$1,552
Latanoprost18$1,466
Fluticasone Propionate35$1,459
Tramadol Hcl16$1,262
Duloxetine Hcl24$1,149

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$55$8,84715 claims
Johnson & JohnsonXarelto$34$6,19811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 84 gerontology providers in Kentucky.

Other gerontology in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →